US Stock MarketDetailed Quotes

Ultragenyx Pharmaceutical (RARE)

Watchlist

26.460
-0.380-1.42%

Close May 13 15:59 ET

26.340
-0.120-0.45%

Pre 06:42 ET

2.61BMarket Cap-4.34P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical (RARE) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-18.67%-197M

-12.56%-466M

-25.86%-99.83M

-36.46%-91.42M

-41.30%-108.75M

12.96%-166M

12.84%-414M

5.69%-79.32M

43.16%-67M

33.74%-76.96M

Net income from continuing operations

-22.52%-185M

-1.05%-575M

3.49%-128.56M

-35.12%-180.41M

12.59%-115.03M

11.53%-151M

6.26%-569M

-7.81%-133.2M

16.37%-133.52M

17.66%-131.6M

Depreciation and amortization

-11.11%8M

-2.78%35M

-7.88%8.79M

-1.72%8.61M

-2.85%8.61M

1.75%9M

38.46%36M

16.12%9.54M

21.78%8.76M

65.30%8.86M

Other non cash items

133.33%2M

-30.00%-52M

-12.86%-17.42M

4.18%-11.04M

-63.13%-17.55M

-161.67%-6M

-3,673.58%-40M

-52.16%-15.43M

-529.06%-11.52M

-39,733.33%-10.76M

Change In working capital

8.93%-51M

-264.29%-23M

-97.42%588K

77.95%54.86M

-237.22%-22.45M

0.03%-56M

187.50%14M

84.06%22.83M

1,001.00%30.83M

128.50%16.36M

-Change in receivables

90.00%19M

8.82%-31M

-60.79%-33.83M

-44.60%5.43M

-683.46%-12.59M

140.15%10M

-47.83%-34M

-2,763.54%-21.04M

257.83%9.79M

114.31%2.16M

-Change in inventory

-300.00%-4M

45.45%-6M

106.67%150K

-123.80%-5.6M

110.78%445K

52.92%-1M

-57.14%-11M

-11.01%-2.25M

27.89%-2.5M

-149.06%-4.13M

-Change in prepaid assets

47.06%-9M

-183.33%-10M

-918.59%-2.74M

-22.12%9.91M

97.64%-165K

-359.42%-17M

-20.00%12M

83.02%-269K

--12.72M

---7M

-Change in payables and accrued expense

-18.75%-57M

-48.94%24M

-20.22%37.01M

317.12%45.12M

-140.02%-10.14M

-35.06%-48M

4,800.00%47M

204.72%46.39M

44.61%10.82M

115.00%25.33M

Cash from discontinued investing activities

Operating cash flow

-18.67%-197M

-12.56%-466M

-25.86%-99.83M

-36.46%-91.42M

-41.30%-108.75M

12.96%-166M

12.84%-414M

5.69%-79.32M

43.16%-67M

33.74%-76.96M

Investing cash flow

Cash flow from continuing investing activities

-140.83%-49M

1,411.11%236M

-170.48%-72.25M

142.53%117.18M

17.34%71.07M

27.07%120M

-110.71%-18M

195.78%102.5M

-528.50%-275.5M

-39.08%60.56M

Net PPE purchase and sale

0.00%-1M

14.29%-6M

-475.46%-938K

20.96%-1.28M

-38.58%-2.78M

68.86%-1M

84.09%-7M

87.77%-163K

56.24%-1.62M

85.59%-2.01M

Net intangibles purchase and sale

66.67%-5M

-15.38%-15M

--0

-50.00%-15M

-333.33%-13M

0.00%-500K

--0

0.00%-2.5M

Net business purchase and sale

----

--0

----

Net investment purchase and sale

-131.39%-43M

6,350.00%258M

-169.59%-71.58M

143.35%118.65M

13.55%73.94M

24.87%137M

-98.19%4M

198.94%102.86M

-500.01%-273.68M

-43.99%65.11M

Net other investing changes

----

50.00%-1M

-11.65%273K

8.87%-185K

-114.63%-88K

51.57%-1M

66.67%-2M

125.27%309K

52.57%-203K

89.70%-41K

Cash from discontinued investing activities

Investing cash flow

-140.83%-49M

1,411.11%236M

-170.48%-72.25M

142.53%117.18M

17.34%71.07M

27.07%120M

-110.71%-18M

195.78%102.5M

-528.50%-275.5M

-39.08%60.56M

Financing cash flow

Cash flow from continuing financing activities

19.80%478M

13,285.13%394.19M

-99.98%2K

-78.27%83.65M

370.69%157K

2.84%399M

-99.11%2.95M

-55.72%11.17M

1,065.78%384.94M

Net common stock issuance

----

-78.06%86M

-43.07%6.27M

--0

----

1.29%392M

-96.70%11.02M

-99.53%117K

----

Proceeds from stock option exercised by employees

----

-99.95%2K

-3.73%3.92M

370.69%157K

33.78%11.26M

-23.30%3.19M

817.87%4.06M

-10.86%4.07M

Net other financing activities

----

5,500.00%392M

----

600.00%7M

--0

----

Cash from discontinued financing activities

Financing cash flow

----

19.80%478M

13,285.13%394.19M

-99.98%2K

-78.27%83.65M

370.69%157K

2.84%399M

-99.11%2.95M

-55.72%11.17M

1,065.78%384.94M

Net cash flow

Beginning cash position

136.96%436M

-15.98%184M

34.01%214.7M

-61.52%188.64M

13.59%139M

-16.13%184M

58.70%219M

103.82%160.21M

355.35%490.26M

33.70%122.37M

Current changes in cash

-434.78%-246M

851.52%248M

749.94%222.12M

107.78%25.76M

-87.48%46.12M

52.26%-46M

-140.74%-33M

-81.25%26.13M

-1,068.89%-331.32M

2,164.18%368.54M

Effect of exchange rate changes

-200.00%-1M

300.00%4M

66.32%-656K

-76.94%294K

618.83%3.36M

247.28%1M

---2M

-403.90%-1.95M

278.07%1.28M

-376.47%-648K

End cash Position

35.97%189M

136.96%436M

34.01%214.7M

-61.52%188.64M

13.59%139M

-15.98%184M

103.82%160.21M

355.35%490.26M

Free cash flow

-11.54%-203M

-12.21%-487M

-25.99%-100.77M

-35.11%-92.7M

-36.90%-111.53M

10.76%-182M

16.86%-434M

6.93%-79.98M

43.56%-68.61M

38.56%-81.47M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-18.67%-197M	-12.56%-466M	-25.86%-99.83M	-36.46%-91.42M	-41.30%-108.75M	12.96%-166M	12.84%-414M	5.69%-79.32M	43.16%-67M	33.74%-76.96M
Net income from continuing operations	-22.52%-185M	-1.05%-575M	3.49%-128.56M	-35.12%-180.41M	12.59%-115.03M	11.53%-151M	6.26%-569M	-7.81%-133.2M	16.37%-133.52M	17.66%-131.6M
Depreciation and amortization	-11.11%8M	-2.78%35M	-7.88%8.79M	-1.72%8.61M	-2.85%8.61M	1.75%9M	38.46%36M	16.12%9.54M	21.78%8.76M	65.30%8.86M
Other non cash items	133.33%2M	-30.00%-52M	-12.86%-17.42M	4.18%-11.04M	-63.13%-17.55M	-161.67%-6M	-3,673.58%-40M	-52.16%-15.43M	-529.06%-11.52M	-39,733.33%-10.76M
Change In working capital	8.93%-51M	-264.29%-23M	-97.42%588K	77.95%54.86M	-237.22%-22.45M	0.03%-56M	187.50%14M	84.06%22.83M	1,001.00%30.83M	128.50%16.36M
-Change in receivables	90.00%19M	8.82%-31M	-60.79%-33.83M	-44.60%5.43M	-683.46%-12.59M	140.15%10M	-47.83%-34M	-2,763.54%-21.04M	257.83%9.79M	114.31%2.16M
-Change in inventory	-300.00%-4M	45.45%-6M	106.67%150K	-123.80%-5.6M	110.78%445K	52.92%-1M	-57.14%-11M	-11.01%-2.25M	27.89%-2.5M	-149.06%-4.13M
-Change in prepaid assets	47.06%-9M	-183.33%-10M	-918.59%-2.74M	-22.12%9.91M	97.64%-165K	-359.42%-17M	-20.00%12M	83.02%-269K	--12.72M	---7M
-Change in payables and accrued expense	-18.75%-57M	-48.94%24M	-20.22%37.01M	317.12%45.12M	-140.02%-10.14M	-35.06%-48M	4,800.00%47M	204.72%46.39M	44.61%10.82M	115.00%25.33M
Cash from discontinued investing activities
Operating cash flow	-18.67%-197M	-12.56%-466M	-25.86%-99.83M	-36.46%-91.42M	-41.30%-108.75M	12.96%-166M	12.84%-414M	5.69%-79.32M	43.16%-67M	33.74%-76.96M
Investing cash flow
Cash flow from continuing investing activities	-140.83%-49M	1,411.11%236M	-170.48%-72.25M	142.53%117.18M	17.34%71.07M	27.07%120M	-110.71%-18M	195.78%102.5M	-528.50%-275.5M	-39.08%60.56M
Net PPE purchase and sale	0.00%-1M	14.29%-6M	-475.46%-938K	20.96%-1.28M	-38.58%-2.78M	68.86%-1M	84.09%-7M	87.77%-163K	56.24%-1.62M	85.59%-2.01M
Net intangibles purchase and sale	66.67%-5M	-15.38%-15M	--0	--0	--0	-50.00%-15M	-333.33%-13M	0.00%-500K	--0	0.00%-2.5M
Net business purchase and sale	----	----	----	----	----	----	--0	----	----	----
Net investment purchase and sale	-131.39%-43M	6,350.00%258M	-169.59%-71.58M	143.35%118.65M	13.55%73.94M	24.87%137M	-98.19%4M	198.94%102.86M	-500.01%-273.68M	-43.99%65.11M
Net other investing changes	----	50.00%-1M	-11.65%273K	8.87%-185K	-114.63%-88K	51.57%-1M	66.67%-2M	125.27%309K	52.57%-203K	89.70%-41K
Cash from discontinued investing activities
Investing cash flow	-140.83%-49M	1,411.11%236M	-170.48%-72.25M	142.53%117.18M	17.34%71.07M	27.07%120M	-110.71%-18M	195.78%102.5M	-528.50%-275.5M	-39.08%60.56M
Financing cash flow
Cash flow from continuing financing activities		19.80%478M	13,285.13%394.19M	-99.98%2K	-78.27%83.65M	370.69%157K	2.84%399M	-99.11%2.95M	-55.72%11.17M	1,065.78%384.94M
Net common stock issuance	----	-78.06%86M	-43.07%6.27M	--0	----	----	1.29%392M	-96.70%11.02M	-99.53%117K	----
Proceeds from stock option exercised by employees	----	----	----	-99.95%2K	-3.73%3.92M	370.69%157K	33.78%11.26M	-23.30%3.19M	817.87%4.06M	-10.86%4.07M
Net other financing activities	----	5,500.00%392M	----	----	----	----	600.00%7M	--0	----	----
Cash from discontinued financing activities
Financing cash flow	----	19.80%478M	13,285.13%394.19M	-99.98%2K	-78.27%83.65M	370.69%157K	2.84%399M	-99.11%2.95M	-55.72%11.17M	1,065.78%384.94M
Net cash flow
Beginning cash position	136.96%436M	-15.98%184M	34.01%214.7M	-61.52%188.64M	13.59%139M	-16.13%184M	58.70%219M	103.82%160.21M	355.35%490.26M	33.70%122.37M
Current changes in cash	-434.78%-246M	851.52%248M	749.94%222.12M	107.78%25.76M	-87.48%46.12M	52.26%-46M	-140.74%-33M	-81.25%26.13M	-1,068.89%-331.32M	2,164.18%368.54M
Effect of exchange rate changes	-200.00%-1M	300.00%4M	66.32%-656K	-76.94%294K	618.83%3.36M	247.28%1M	---2M	-403.90%-1.95M	278.07%1.28M	-376.47%-648K
End cash Position	35.97%189M	136.96%436M	136.96%436M	34.01%214.7M	-61.52%188.64M	13.59%139M	-15.98%184M	-15.98%184M	103.82%160.21M	355.35%490.26M
Free cash flow	-11.54%-203M	-12.21%-487M	-25.99%-100.77M	-35.11%-92.7M	-36.90%-111.53M	10.76%-182M	16.86%-434M	6.93%-79.98M	43.56%-68.61M	38.56%-81.47M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm